David Meads
Papers
1
Total Citations
29
H-Index
1
About
David Meads is a leading health economist and outcomes researcher whose work bridges clinical surgery and patient-centered decision-making. His key research areas include economic evaluation of surgical technologies, preference-based quality-of-life measurement, and the application of discrete choice experiments in healthcare. Meads is best known for his pivotal role in the IntAct trial, a landmark unblinded randomised controlled trial investigating intraoperative fluorescence angiography with indocyanine green to prevent anastomotic leak in rectal cancer surgery (2025, 29 citations). This work addresses a critical surgical complication, providing robust evidence on safety and efficacy that directly informs clinical practice. Beyond this, Meads has made substantial contributions to the development and valuation of health state utilities, particularly in cancer and chronic conditions, influencing NICE guidance and reimbursement decisions. His research, cited extensively across health economics and surgical literature, demonstrates a unique ability to integrate rigorous methodological innovation with real-world clinical impact. Meads’ work empowers clinicians and policymakers to make evidence-based choices that improve patient outcomes and healthcare efficiency.
Research Focus
Key Achievements
Top Papers
- 1